Anti-CD3-activated killer T cells: Interferon-γ and interleukin-10 cross-regulate granzyme B expression and the induction of major histocompatibility complex-unrestricted cytotoxicity

Journal of Interferon and Cytokine Research

Volumn 16, Issue 7, 1996, Pages 537-546

  Fitzpatrick, Lyn ^a   Makrigiannis, Andrew P ^a   Kaiser, Michael ^a   Hoskin, David W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DNA; GAMMA INTERFERON; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY CD3; NEUTRALIZING ANTIBODY; PERFORIN; SERINE PROTEINASE;

ANIMAL CELL; ARTICLE; COLORIMETRY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DNA SYNTHESIS; ENZYME ACTIVITY; FLOW CYTOMETRY; LYMPHOCYTE CULTURE; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALIA;

EID: 0029822896     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.537     Document Type: Article

References (54)

1. BERKE, G. (1995). The CTL's kiss of death. Cell 81, 9-12.
2. SMYTH, M.J., and TRAPANI, J.A. (1995). Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol. Today, 16, 202-206.
3. GERSHENFELD, H.K., HERSHBERGER, R.J., SHOWS, T.B., and WEISSMAN, I. (1988). Cloning and chromosomal assignment of a human cDNA encoding a T cell- and natural killer cell-specific trypsin-like serine protease. Proc. Natl. Acad. Sci. USA 85, 1184-1188.
4. POE, M., BLAKE, J.T., BOULTON, D.A., GAMMON, M., SIGAL, N.H., WU, J.K., and ZWEERINK, H.J. (1991). Human cytotoxic lymphocyte granzyme B: its purification from granules and the characterization of substrate and inhibitor specificity. J. Biol. Chem. 266, 98-103.
5. MASSON, D., and TSCHOPP, J. (1987). A family of serine esterases in lytic granules of cytolytic T lymphocytes. Cell 49, 679-685.
6. SHIVER, J.W., SU, L., and HENKART, P.A. (1992). Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A. Cell 71, 315-319.
7. SHI, L., KRAUT, R.P., AEBERSOLD, R., and GREENBERG, A.H. (1992). A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J. Exp. Med. 175, 553-566.
8. ODAKE, S., KAM, C.-M., NARASIMHAN, L., POE, M., BLAKE, J.T., KRAHENBUHL, O., TSCHOPP, J., and POWERS, J.C. (1991). Human and murine serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins. Biochemistry 30, 2217-2224.
9. TALENTO, A., NGUYEN, M., LAW, S., WU, J.K., POE, M., BLAKE, J.T., PATEL, M., WU, T.-J., MANYAK, C.L., SILBERKLANG, M., MARK, G., SPRINGER, M., SIGHAL, N.H., WEISSMAN, I.L., BLEACKLEY, R.C., PODACK, E.R., TYKOCINSKI, M.L., and KOO, G.C. (1992). Transfection of mouse cytotoxic T lymphocyte with an antisense granzyme A vector reduces lytic activity. J. Immunol. 149, 4009-4015.
10. HEUSEL, J.W., WESSELSCHMIDT, R.L., SHRESTA, S., RUSSEL, J.H., and LEY, T.J. (1994). Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76, 977-987.
11. MUELLER, D., GERSHENFELD, H.K., LOBE, C.G., OKADA, C.Y., BLEACKLEY, R.C., and WEISSMAN, I.L. (1988). A high proportion of T-lymphocytes that infiltrate H-2-incompatible heart allografts in vivo express genes encoding cytotoxic cell-specific serine proteases, but do not express the MEL-14-defined lymph node homing receptor. J. Exp. Med. 167, 1124-1136.
12. GRIFFITHS, G.M., NAMIKAWA, R., MUELLER, C., LIU, C.-C., YOUNG, J.D.-E., BILLINGHAM, M., and WEISSMAN, I. (1991). Granzyme A and perform as markers for rejection in cardiac transplantation. Eur. J. Immunol. 21, 687-692.
13. LEGROS-MAIDA, S., SOULIE, A., BENVENUTI, C., WARGNIER, A., VALLEE, N., BERTHOU, D., GUILLET, J., SASPORTES, M., and SIGAUX, N. (1994). Granzyme B and perform can be used as predictive markers of acute rejection in heart transplantation. Eur. J. Immunol. 24, 229-233.
14. KAISER, M., and HOSKIN, D.W. (1992). Expression and utilization of chymotrypsin-like but not trypsin-like serine protease enzymes by nonspecific T killer cells activated by anti-CD3 monoclonal antibody. Cell. Immunol. 141, 84-98.
15. SCOTT, D.E., GAUSE, W.C., FINKELMAN, F.D., and STEINBERG, A.D. (1990). Anti-CD3 antibody induces rapid expression of cytokine genes in vivo. J. Immunol. 145, 2183-2188.
16. DUREZ, P., ABRAMOWICZ, D., GERARD, C., VAN MECHELEN, M., AMRAOUI, Z., DUBOIS, C., LEO, O., VELU, T., and GOLDMAN, M. (1993). In vivo induction of interleukin-10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: Differential modulation by cyclosporin A. J. Exp. Med. 177, 551-555.
17. MANYAK, C.L., NORTON, G.P., LOBE, C.G., BLEACKLEY, R.C., GERSHENFELD, H.K., WEISSMAN, I.L., KUMAR, V., SIGHAL, N.H., and KOO, G.C. (1989). IL-2 induces expression of serine protease enzymes and genes in natural killer and non-specific T killer cells. J. Immunol. 142, 3707-3713.
18. LIU, C.-C., JOAG, S.V., KWON, B.S., and YOUNG, J.D.-E. (1990). Induction of perform and serine esterases in a murine cytotoxic T lymphocyte clone. J. Immunol. 144, 1196-1201.
19. KAISER, M., BROOKS-KAISER, J., FITZPATRICK, L., BLEACKLEY, R.C., and HOSKIN, D.W. (1993). .Cytotoxic cell proteinase gene expression and cytolytic activity by anti-CD3-activated cytotoxic T lymphocytes is sensitive to cyclosporin A but is not dependent on IL-2 synthesis. J. Leukocyte Biol. 54, 458-464.
20. LEO, O., FOO, M., SACHS, D.H., SAMELSON, L.E., and BLUESTONE, J.A. (1987). Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84, 1374-1378.
21. JULIUS, M.H., SIMPSON, E., and HERZENGERG, L.A. (1973). A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3, 645-649.
22. OKAMOTO, T., HARADA, M., SHINOMIYA, Y., MATSUZAKI, G., and NOMOTO, K. (1995). The antitumor effect of tumor-draining lymph node cells activated by both anti-CD3 monoclonal antibody and activated B cells as costimulatory-signal-providing cells. Cancer Immunol. Immunother. 40, 173-181.
23. STANKOVA, J., HOSKIN, D.W., and RODER, J.C. (1989). Murine anti-CD3 monoclonal antibody induces potent cytolytic activity in both T and NK cell populations. Cell. Immunol. 121, 13-29.
24. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
25. LOBE, C.G., HAVELE, C., and BLEACKLEY, R.C. (1986). Cloning of two genes that are specifically expressed in activated cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 83, 1448-1452.
26. SUDA, T., OKAZAKI, T., NAITO, Y., YOKOTA, T., ARAI, N., OZAKI, S., NAKAO, K., and NAGATA, S. (1995). Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154, 3806-3813.
27. GARNER, R., HELGASON, C.D., ATKINSON, E.A., PINKOSKI, M.J., OSTERGAARD, H.L., SORENSEN, O., FU, A., LAPCHAK, P.H., RABINOVITCH, A., McELHANEY, J.E., BERKE, G., and BLEACKLEY, R.C. (1994). Characterization of a granule-independent lytic mechanism used by CTL hybridomas. J. Immunol. 153, 5413-5421.
28. ENARI, M., HUG, H., and NAGATA, S. (1995). Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375, 78-81.
29. WALSH, C.M., GLASS, A.A., CHUI, V., and CLARK, W.R. (1994). The role of the Fas lytic pathway in a perform-less CTL hybridoma. J. Immunol. 153, 2506-2514.
30. EISCHEN, C.M., DICK, C.J., and LEIBSON, P.J. (1994). Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J. Immunol. 153, 1947-1954.
31. PRENDERGAST, J.A., HELGASON, C.D., and BLEACKLEY, C.R. (1992). Qualitative polymerase chain reaction analysis of cytotoxic cell proteinase gene transcripts in T cells. Pattern of expression is dependent on the nature of the stimulus. J. Biol. Chem. 267, 5090-5095.
32. MAPARA, M., BARGOU, R., ZUGCK, C, DOHNER, H., USTAOGLU, F., JONKER, R.R., KRAMMER, P.H., and DORKEN, B. (1993). APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur. J. Immunol. 23, 702-708.
33. OWEN-SCHAUB, L.B., RADINSKY, R., KRUZEL, E., BERRY, K., and YONEHARA, S. (1994). Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res. 54, 1580-1586.
34. NAGATA, S., and GOLSTEIN, P. (1995). The Fas death factor. Science 267, 1449-1462.
35. KAGI, D., LEDERMANN, B., BURKI, K., SEILER, P., ODERMATT, B., OLSEN, K.J., PODACK, E.R., ZINKERNAGEL, R., and HENGARTNER, H. (1994). Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369, 31-37.
36. + T cells. J. Exp. Med. 171, 1269-1281.
37. LIU, C.-C., RAFII, S., GRANELLI-PIPERNO, A., TRAPANI, J.A., and YOUNG, J.D.-E. (1989). Perform and serine esterase gene expression in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A. J. Exp. Med. 170, 2105-2118.
38. GAJEWSKI, T.F., and FITCH, F.W. (1988). Antiproliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 140, 4245-4252.
39. CESANO, A., VISONNEAU, S., CLARK, S.C., and SANTOLI, D. (1993). Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. J. Immunol. 151, 2943-2957.
40. CHAN, S.H., PURUSSIA, B., GUPTA, J.W., KOBAYASHI, M., POSPISIL, M., YOUNG, H.A., WOLF, S.F., YOUNG, D., CLARK, S.C., and TRINCHIERI, G. (1991). Induction of interferon production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173, 869-879.
41. WANG, L., GOILLOT, E., and TEPPER, R.I. (1994). IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivo. Cell. Immunol. 159, 152-169.
42. D'ANDREA, A., ASTE-AMEZAGA, M., VALIANTE, N.M., MA, X., KUBIN, M., and TRINCHIERI, G. (1993). Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178, 1041-1048.
43. GERMANN, T., GATELY, M.K., SCHOENHAUT, D.S., LOHOFF, M., MATTNER, F., FISCHER, S., JIN, S.C., SCHMITT, E., and RUDE, E. (1993). Interleukin-12/Tcell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Eur. J. Immunol. 23, 1762-1770.
44. MOSMANN, T.R. (1994). Properties and functions of interleukin-10. Adv. Immunol. 56, 1-19.
45. DING, L., LINSLEY, P.S., HUANG, L.-Y., GERMAIN, L.N., and SHEVACH, E.M. (1993). IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the upregulation of B7 expression. J. Immunol. 151, 1224-1234.
46. WANG, P., WU, P., SIEGEL, M.I., EGAN, R.W., and BILLAH, M.M. (1994). IL-10 inhibits the transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 153, 811-816.
47. MAEDA, H., OGOSHI, S., and FUJIMOTO, S. (1994). Involvement of Th2-like T cells in regulating allograft reactivity against MHC class II-disparate antigen. Transplant. Proc. 26, 847-848.
48. LOWIN, B., BEERMAN, F., SCHMIDT, A., and TSCHOPP, J. (1994). A null mutation in the perform gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 91, 11571-11575.
49. SPRINGER, T.A. (1990). Adhesion receptors of the immune system. Nature 346, 425-434.
50. SCHOOF, D.D., SELLECK, C.M., MASSARO, A.F., JUNG, S.-E., and EBERLEIN, T.J. (1990). Activation of human tumor-infiltrating lymphocytes by monoclonal antibodies directed to the CD3 complex. Cancer Res. 50, 1138-1143.
51. + tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro. Eur. J. Immunol. 24, 1966-1973.
52. KHARKEVITCH, D.D., SEITO, D., BALCH, G.C., MAEDA, T., BALCH, C.M., and ITOH, K. (1994). Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma. Int. J. Cancer 58, 317-323.
53. KIM, J., MODLIN, R.L., MOY, R.L., DUBINETT, S.M., McHUGH, T., NICKOLOFF, B.J., and UYEMURA, K. (1995). IL-10 production in cutaneous basal and squamous cell carcinomas. J. Immunol. 155, 2240-2247.
54. HUANG, M., WANG, J., LEE, P., SHARMAN, S., MAO, J.T., MEISSNER, H., UYEMURA, K., MODLIN, R., WOLLMAN, J., and DUBINETTT, S.M. (1995). Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res. 55, 3847-3853.